AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2018
Oct 24, 2018
32870_dirs_2018-10-24_feb98d1d-d967-4447-9166-5ba2beb0870b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-10-17
Reporting Person: Havey Adam (EVP, Business Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-17 | Common Stock | S | 314 | $63.50 | Disposed | 29253 | Direct |
Footnotes
F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
F2: This form 4/A is being filed to amend the sales price of the shares.
More from Emergent BioSolutions Inc.
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Regulatory Filings
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 3